News und Analysen

Executives at molecular diagnostics company Natera have recently sold shares worth over $1.2 million, even as the company demonstrates impressive market performance. Board Chairman Matthew

Quest Diagnostics, a leading provider of diagnostic information services, experienced a significant 4.75% decline on the New York Stock Exchange following disappointing long-term growth projections

Die Aktie des Lidar-Technologiespezialisten Microvision verzeichnete am 17. März 2025 einen Kursanstieg um 2,34% auf 1,31 USD. Trotz dieser positiven Tagesentwicklung bleibt die langfristige Tendenz

Die Teleflex Aktie verzeichnete am vergangenen Freitag einen moderaten Anstieg von 0,80% und erreichte damit einen Kurs von 126,50 EUR. Diese positive Entwicklung steht im Kontrast zur schwachen

Iridex Corporation (NASDAQ: IRIX) shares experienced significant fluctuations last week, with March 13, 2025 showing particularly volatile trading patterns. The Mountain View, California-based

Cerus Corporation's leadership team has recently executed several stock sales, drawing investor attention as the transactions occurred while shares traded near their 52-week low. The company's CEO

Align Technology, a digital dentistry leader valued at $12.1 billion, has announced the European Union and UK launch of its AI-powered "Align X-ray Insights" diagnostic software. The cloud-based

The leadership team at CryoLife, a medical technology company with a market capitalization approaching $1 billion, has recently executed multiple stock transactions. Chief Financial Officer Lance

The British biotechnology firm Avacta Therapeutics has reported significant progress with its lead drug candidate AVA6000, a modified form of the chemotherapy drug doxorubicin. In a recently

In early March 2025, Merit Medical Systems' leadership team executed significant stock transactions totaling over $7 million. CEO Fred Lampropoulos sold 34,319 shares at prices between $103.75 and

Cerus Corp (NASDAQ: CERS) recently saw several top executives sell company shares as part of a pre-established trading plan in early March 2025. CEO William Greenman sold 23,023 shares at an average

Several high-ranking executives at Penumbra Inc. have recently sold substantial amounts of company stock, with transactions beginning in early March 2025. Board member Arani Bose divested shares

Veeva Systems has introduced Commercial Pulse, a new data offering designed to enhance market segmentation and targeting for life sciences companies. This solution provides quarterly updates on

Die Agfa-Gevaert-Gruppe zeigt weiterhin eine schwache Performance an den Börsen. Der belgische Bildgebungs- und IT-Lösungsanbieter verzeichnete gestern einen Kursrückgang von 0,88 Prozent auf 0,79

Merit Medical Systems Inc., a medical technology company with a market capitalization of $6.08 billion, has experienced significant stock transactions by its leadership team. The company's chief

Stereotaxis (NYSE: STXS), a pioneer in robotic technologies for minimally invasive endovascular procedures, has filed regulatory applications with the U.S. Food and Drug Administration for two